Catalent Bolsters Clinical Supply Capabilities
Catalent Pharma Solutions has completed a $5.5 million expansion program at its more than 200,000 square foot Philadelphia, PA, site to provide additional clinical packaging and storage capacity.
The facility, which is located near many customers and major transportation hubs, is also one of the largest sites in Catalent's global clinical supply network. The investment has provided the site with a 40% increase in pallet space for both refrigerated and ambient clinical storage, additional cold chain packaging areas, and a new clinical label control area. The building also features a new campus-wide environmental monitoring and building management system.
"The expansion not only allows us to meet the demand for additional capacity to serve large-scale clinical studies today, but also provides the space necessary for future growth," said Albert Quintero, general manager, clinical supply services, Catalent. "We look forward to welcoming new and existing customers at these new facilities."
With sites in the U.S., UK, Germany, Japan and China, and an extended network of over 50 depots, Catalent's clinical supply services team has the capability and expertise to handle a broad range of international compliance and distribution requirements, and so help to expedite clinical trials by ensuring customers are reliably supplied where and when needed around the globe.
2026-09-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
8th Annual Pharma Manufacturing and Automation Convention 2026
-
Pharma Manufacturing & Automation Excellence Awards 2026
-
CPHI Korea 2026: A Leading Gateway to Korea’s Pharmaceutical and Biopharma Market
-
Pharmaconex
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
Catalent Faces Continuous Losses and Operational Challenges in 2023, Reports $715 Million Net Loss in Q1 2024
-
Is the class solidified? From Biotech to Pharma
Recommend Reading
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
McKinsey Pays to Close a Purdue Liability Chapter
-
Isopropanol vs. Isopropyl Alcohol: Are They Different? (Uses & Safety)
-
Polyester Bottle Flakes Slightly Lowered on May 13, Showing Weak and Volatile Trends
-
September Petrochemical Prices for Gasoline and Diesel Mostly Fluctuate
-
Weather Themes Remain; Palm Oil Futures Expected to Rise
-
Weak Downward Trend in China's Soda Ash Market in September
-
Premium Global Chemical Sourcing Requests (11-13May, 2026)